Astellas Pharma (China)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
61%
Total
Publications
215
Total Open
Publications
132
Total
Citations
9.3K
Open Access
Percentage
61%
Total
Publications
215
Total Open
Publications
132
Total
Citations
9.3K
Breakdown
Publisher Open
28%
Both
19%
Other Platform Open
14%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 19%
19
Hybrid 33%
33
No Guarantees 48%
49
Other Platform Open
Domain 79%
57
Institution 25%
18
Preprint 15%
11
Public 10%
7
Other Internet 10%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 57 |
Europe PMC | Domain | 35 |
Semantic Scholar | Public | 7 |
Research Square | Preprint | 6 |
University College London - UCL Discovery | Institution | 3 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 3 |
DOI | Other Internet | 3 |
bioRxiv | Preprint | 3 |
The University of Manchester - Research Explorer | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 2 |